R&D Costs and Returns to New Drug Development: a Review of the Evidence
Year of publication: |
2012
|
---|---|
Authors: | DiMasi, Joseph A. ; Grabowski, Henry G. |
Published in: |
The Oxford handbook of the economics of the biopharmaceutical industry. - Oxford [u.a.] : Oxford Univ. Press, ISBN 978-0-19-996874-9. - 2012
|
Subject: | Arzneimittel | Pharmaceuticals | Pharmaindustrie | Pharmaceutical industry |
-
Beyond the pill : the move towards value-addded services in the pharmaceutical industry
Wenzel, Meike, (2014)
-
Substitutability between drugs, innovation, and fiscal policy in the pharmaceutical industry
Mello-Sampayo, Felipa de, (2015)
-
Patents and R&D expenditure effects on equity returns in pharmaceutical industry
Feyzrakhmanova, Martina, (2016)
- More ...
-
The cost of biopharmaceutical R&D : is biotech diffent?
DiMasi, Joseph A., (2007)
-
Grabowski, Henry G., (2009)
-
Extraordinary claims require extraordinary evidence
Light, Donald, (2005)
- More ...